Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Radiotherapy +/- Goserelin in Recurrent Prostate Cancer
NCT00423475Phase 3Completed
- Sponsor
- Unicancer
- Start
- Oct 2006
- Primary completion
- Mar 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of goserelin in prostate cancer (PCa), sponsored by Unicancer. Started Oct 2006; status: completed.
02
Drugs
goserelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00423475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423475.